These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10398207)

  • 1. Transforming growth factor-beta2 is elevated in skeletal muscle disorders.
    Murakami N; McLennan IS; Nonaka I; Koishi K; Baker C; Hammond-Tooke G
    Muscle Nerve; 1999 Jul; 22(7):889-98. PubMed ID: 10398207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy.
    Yamazaki M; Minota S; Sakurai H; Miyazono K; Yamada A; Kanazawa I; Kawai M
    Am J Pathol; 1994 Feb; 144(2):221-6. PubMed ID: 8311110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome expression in the skeletal muscles of patients with muscular dystrophy.
    Kumamoto T; Fujimoto S; Ito T; Horinouchi H; Ueyama H; Tsuda T
    Acta Neuropathol; 2000 Dec; 100(6):595-602. PubMed ID: 11078210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular localisation of transforming growth factor-beta 2 and -beta 3 (TGF-beta2, TGF-beta3) in damaged and regenerating skeletal muscles.
    McLennan IS; Koishi K
    Dev Dyn; 1997 Feb; 208(2):278-89. PubMed ID: 9022064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy.
    Sun G; Haginoya K; Chiba Y; Uematsu M; Hino-Fukuyo N; Tanaka S; Onuma A; Iinuma K; Tsuchiya S
    J Neurol Sci; 2010 Oct; 297(1-2):19-28. PubMed ID: 20655547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALS skeletal muscle shows enhanced TGF-β signaling, fibrosis and induction of fibro/adipogenic progenitor markers.
    Gonzalez D; Contreras O; Rebolledo DL; Espinoza JP; van Zundert B; Brandan E
    PLoS One; 2017; 12(5):e0177649. PubMed ID: 28520806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.
    Bernasconi P; Torchiana E; Confalonieri P; Brugnoni R; Barresi R; Mora M; Cornelio F; Morandi L; Mantegazza R
    J Clin Invest; 1995 Aug; 96(2):1137-44. PubMed ID: 7635950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of clathrin in distal myopathy with rimmed vacuoles.
    Kumamoto T; Abe T; Nagao S; Ueyama H; Tsuda T
    Acta Neuropathol; 1998 Jun; 95(6):571-5. PubMed ID: 9650748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
    Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
    Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of various isoforms of neural cell adhesive molecules and their highly polysialylated counterparts in diseased human muscles.
    Figarella-Branger D; Nedelec J; Pellissier JF; Boucraut J; Bianco N; Rougon G
    J Neurol Sci; 1990 Aug; 98(1):21-36. PubMed ID: 2230829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
    Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
    J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta1 and fibrosis in congenital muscular dystrophies.
    Bernasconi P; Di Blasi C; Mora M; Morandi L; Galbiati S; Confalonieri P; Cornelio F; Mantegazza R
    Neuromuscul Disord; 1999 Jan; 9(1):28-33. PubMed ID: 10063832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light-microscopic study of the beta 1 integrin subunit in human skeletal muscle.
    Heub D; Neundörfer B
    Clin Neuropathol; 1997; 16(6):319-27. PubMed ID: 9401799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dystrophin-related protein in skeletal muscles in neuromuscular disorders: immunohistochemical study.
    Takemitsu M; Nonaka I; Sugita H
    Acta Neuropathol; 1993; 85(3):256-9. PubMed ID: 8460531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of connective tissue growth factor in progressive muscular dystrophy].
    Sun GL; Yao F; Jiang HK; Li P; Kazuhiro H
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):753-7. PubMed ID: 16255854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible neurogenic factor in muscular dystrophy: its similarity to denervation atrophy.
    Dastur DK; Razzak ZA
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):399-410. PubMed ID: 4714102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light-microscopic study of insulin like growth factor II (IGF-II) and insulin like growth factor I receptor (IGF-I-R) in myopathy.
    Heuss DF
    Neurol Res; 1997 Apr; 19(2):153-9. PubMed ID: 9175144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta following skeletal muscle strain injury in rats.
    Smith CA; Stauber F; Waters C; Alway SE; Stauber WT
    J Appl Physiol (1985); 2007 Feb; 102(2):755-61. PubMed ID: 17068209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light and electron microscopic studies on localization of myoglobin in skeletal muscle cells in neuromuscular diseases.
    Kawai H; Sebe T; Nishino H; Nishida Y; Saito S
    Muscle Nerve; 1991 Apr; 14(4):342-7. PubMed ID: 2027351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifying muscular dystrophy through transforming growth factor-β.
    Ceco E; McNally EM
    FEBS J; 2013 Sep; 280(17):4198-209. PubMed ID: 23551962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.